berk-cognitiveremission-2016.pdf (709.61 kB)
Download fileCognitive remission: A novel objective for the treatment of major depression?
journal contribution
posted on 2016-01-22, 00:00 authored by B Bortolato, K W Miskowiak, C A Köhler, M. Maes, Brisa Simoes Fernandes, Michael BerkMichael Berk, A F CarvalhoCognitive remission: A novel objective for the treatment of major depression?
History
Journal
BMC MedicineVolume
14Issue
1Article number
ARTN 9Publisher
BMCLocation
EnglandPublisher DOI
ISSN
1741-7015eISSN
1741-7015Language
EnglishPublication classification
C Journal article; C1 Refereed article in a scholarly journalCopyright notice
2016, The AuthorsUsage metrics
Read the peer-reviewed publication
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineAntidepressantsCognitionCognitive enhancersErythropoietinLisdexamfetamine dimesylateMajor depressionNovel targetsVortioxetinePsychiatryTREATMENT-RESISTANT DEPRESSIONACETYL-L-CARNITINEALPHA-LIPOIC ACIDDIRECT-CURRENT STIMULATIONDOUBLE-BLINDCONTROLLED-TRIALEXECUTIVE DYSFUNCTIONTREATMENT RESPONSEUNIPOLAR DEPRESSIONBIPOLAR DISORDERadultantidepressive agentsattentioncognition disordersdepressive disorder, majorhumansmemorymeta-analysis as topicnootropic agentsrecovery of functionremission induction